View in EDS HTML Full Text PDF Full Text

A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies.

Saved in:
Bibliographic Details
Title: A phase I trial of the mTOR inhibitor temsirolimus in combination with capecitabine in patients with advanced malignancies.
Authors: Trivedi, Neel D.1 (AUTHOR), Armstrong, Samantha1 (AUTHOR), Wang, Hongkun1 (AUTHOR), Hartley, Marion2 (AUTHOR), Deeken, John3 (AUTHOR), Ruth He, A.1 (AUTHOR), Subramaniam, Deepa1 (AUTHOR), Melville, Heather1 (AUTHOR), Albanese, Chris1 (AUTHOR), Marshall, John L.1 (AUTHOR), Hwang, Jimmy4 (AUTHOR), Pishvaian, Michael J.5 (AUTHOR) mpishva1@jh.edu
Source: Cancer Medicine. Mar2021, Vol. 10 Issue 6, p1944-1954. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20457634
DOI:10.1002/cam4.3672